ACESION PHARMA ApS
CVR number: 34083738
Nordre Fasanvej 215, 2000 Frederiksberg
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | |||||
| Other operating expenses | -47 470.00 | -36 311.00 | -37 897.00 | -56 635.00 | -53 020.00 |
| EBIT | -47 470.00 | -36 311.00 | -37 897.00 | -56 635.00 | -53 020.00 |
| Other financial income | 3 574.00 | 9 309.00 | 12 242.00 | 2 600.00 | 1 006.00 |
| Other financial expenses | -4 368.00 | -9 926.00 | -7 398.00 | -6 130.00 | -3 811.00 |
| Pre-tax profit | -48 265.00 | -36 928.00 | -33 053.00 | -60 165.00 | -55 824.00 |
| Income taxes | 5 500.00 | 5 500.00 | 7 896.00 | 13 385.00 | 12 975.00 |
| Net earnings | -42 765.00 | -31 428.00 | -25 157.00 | -46 780.00 | -42 849.00 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Other tangible assets | 422.00 | 210.00 | 204.00 | 1 683.00 | |
| Tangible assets total | 422.00 | 210.00 | 204.00 | 1 683.00 | |
| Investments total | |||||
| Non-current prepayments and accrued income | 85.00 | 85.00 | 77.00 | 78.00 | 155.00 |
| Long term receivables total | 85.00 | 85.00 | 77.00 | 78.00 | 155.00 |
| Inventories total | |||||
| Current other receivables | 3 769.00 | 3 945.00 | 1 556.00 | 702.00 | 2 088.00 |
| Current deferred tax assets | 5 500.00 | 5 500.00 | 7 896.00 | 13 385.00 | 12 909.00 |
| Short term receivables total | 9 269.00 | 9 445.00 | 9 452.00 | 14 087.00 | 14 997.00 |
| Cash and bank deposits | 22 019.00 | 54 793.00 | 24 221.00 | 39 026.00 | 149 104.00 |
| Cash and cash equivalents | 22 019.00 | 54 793.00 | 24 221.00 | 39 026.00 | 149 104.00 |
| Balance sheet total (assets) | 31 795.00 | 64 533.00 | 33 954.00 | 53 191.00 | 165 939.00 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 7 548.00 | 8 226.00 | 13 246.00 | 70 496.00 | 115 238.00 |
| Share premium account | 126 277.00 | 140 509.00 | 190 406.00 | 190 406.00 | 297 523.00 |
| Other reserves | 1.00 | ||||
| Retained earnings | -95 764.00 | - 137 355.00 | - 168 152.00 | - 191 139.00 | - 239 113.00 |
| Profit of the financial year | -42 765.00 | -31 428.00 | -25 157.00 | -46 780.00 | -42 849.00 |
| Shareholders equity total | -4 704.00 | -20 048.00 | 10 344.00 | 22 983.00 | 130 799.00 |
| Non-current loans from credit institutions | 13 056.00 | 16 309.00 | |||
| Non-current leasing loans | 250.00 | 590.00 | |||
| Non-current other liabilities | 226.00 | 30 537.00 | 1 383.00 | 18 489.00 | 13 449.00 |
| Non-current liabilities total | 476.00 | 43 593.00 | 17 692.00 | 18 489.00 | 14 039.00 |
| Current loans from credit institutions | 1 883.00 | 8 704.00 | |||
| Current leasing loans | 229.00 | 250.00 | 239.00 | 207.00 | |
| Current trade creditors | 2 815.00 | 3 905.00 | 3 350.00 | 5 040.00 | 9 477.00 |
| Other non-interest bearing current liabilities | 32 980.00 | 36 833.00 | 2 330.00 | 4 796.00 | 2 713.00 |
| Current liabilities total | 36 024.00 | 40 988.00 | 5 919.00 | 11 719.00 | 21 101.00 |
| Balance sheet total (liabilities) | 31 796.00 | 64 533.00 | 33 955.00 | 53 191.00 | 165 939.00 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.